Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3377666 | 0.90 | CETP (0.56) | CETPNR1I2 | |
| SCHEMBL22222466 | 0.90 | CETP (0.54) | CETPNR1I2 | |
| SCHEMBL21034042 | 0.88 | CETP (0.54) | CETPNR1I2 | |
| SCHEMBL3377660 | 0.88 | CETP (0.54) | CETPNR1I2 | |
| SCHEMBL28102308 | 0.88 | CETP (0.54) | CETPNR1I2 | |
| SCHEMBL20794179 | 0.86 | CETP (0.63) | CETPNR1I2 | |
| SCHEMBL17244388 | 0.86 | CETP (0.55) | CETPNR1I2 | |
| SCHEMBL17546257 | 0.86 | CETP (0.66) | CETPNR1I2 | |
| SCHEMBL531553 | 0.86 | CETP (0.63) | CETPNR1I2 | |
| SCHEMBL9955476 | 0.85 | CETP (0.62) | CETPNR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020030814-A1 | METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2020-02-13 | — | — | WO | disclosed |
| WO-2019043018-A1 | METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS | DALCOR PHARMA UK LTD., STOCKPORT ZUG BRANCH (CH) | 2019-03-07 | — | — | WO | disclosed |